Independent validation of the PrecivityAD2™ blood test to identify presence or absence of brain amyloid pathology in individuals with cognitive impairment. - Coppinger J; West T; Kirmess KM; Fogelman I; Ray S; Aurora S; Verghese PB; Braunstein JB; Yarasheski KE (MedRxiv : the preprint server for health sciences, 2025)